{"id":26668,"date":"2024-10-18T08:30:00","date_gmt":"2024-10-18T15:30:00","guid":{"rendered":"https:\/\/ameripharmaspecialty.com\/?p=26668"},"modified":"2024-10-17T12:55:05","modified_gmt":"2024-10-17T19:55:05","slug":"ivig-for-multiple-myeloma-mm","status":"publish","type":"post","link":"https:\/\/ameripharmaspecialty.com\/zh\/ivig\/ivig-for-multiple-myeloma-mm\/","title":{"rendered":"\u9759\u8109\u6ce8\u5c04\u514d\u75ab\u7403\u86cb\u767d\uff08IVIG\uff09\u6cbb\u7597\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\uff08MM\uff09"},"content":{"rendered":"<p>IVIG \u7528\u4e8e\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u60a3\u8005\u7684\u652f\u6301\u6cbb\u7597\u3002\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u662f\u4e00\u79cd\u7f55\u89c1\u7684\u8840\u764c\uff0c\u5f62\u6210\u4e8e\u6d46\u7ec6\u80de\u3002\u6d46\u7ec6\u80de\u662f\u4e00\u79cd\u767d\u7ec6\u80de\uff0c\u5728\u6b63\u5e38\u60c5\u51b5\u4e0b\u4f1a\u4ea7\u751f\u6297\u4f53\u6765\u62b5\u6297\u611f\u67d3\u3002&nbsp;<\/p>\n\n\n\n<div  id=\"call-to-action-045b3c94ff4724cb68801e4940692f8f\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\t\u83b7\u5f97 IVIG \u5171\u540c\u652f\u4ed8\u63f4\u52a9\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\"> (877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<p>\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u60a3\u8005\u7684\u764c\u6027\u6d46\u7ec6\u80de\u65e0\u6cd5\u4ea7\u751f\u6709\u6548\u7684\u6297\u4f53\uff0c\u56e0\u6b64\u66f4\u5bb9\u6613\u53d7\u5230\u611f\u67d3\u3002\u7814\u7a76\u8868\u660e\uff0c\u53cd\u590d\u611f\u67d3\u662f\u5bfc\u81f4\u60a3\u8005\u6b7b\u4ea1\u7684\u6f5c\u5728\u539f\u56e0\u4e4b\u4e00\u3002 <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S2152265021000537\">22% \u81f3 45%<\/a> \u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u60a3\u8005\u3002&nbsp;<\/p>\n\n\n\n<p>\u533b\u751f\u901a\u5e38\u5efa\u8bae\u91c7\u7528 IVIG \u7597\u6cd5\u6765\u964d\u4f4e\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u60a3\u8005\u7684\u6b7b\u4ea1\u7387\u548c\u53d1\u75c5\u7387\u3002&nbsp;<\/p>\n\n\n\n<p>\u8ba9\u6211\u4eec\u56de\u987e\u4e00\u4e0b\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u7684\u57fa\u672c\u77e5\u8bc6\uff0c\u5305\u62ec\u5b83\u5bf9\u514d\u75ab\u7cfb\u7edf\u7684\u5f71\u54cd\uff0c\u4ee5\u53ca IVIG \u7597\u6cd5\u5982\u4f55\u5e2e\u52a9\u60a3\u6709\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u7684\u60a3\u8005\u3002&nbsp;<\/p>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_82_2 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"\u5207\u6362\u76ee\u5f55\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">\u5207\u6362<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/ivig\/ivig-for-multiple-myeloma-mm\/#Basics_of_Multiple_Myeloma_and_How_It_Affects_the_Immune_System\" >\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u7684\u57fa\u7840\u77e5\u8bc6\u53ca\u5176\u5bf9\u514d\u75ab\u7cfb\u7edf\u7684\u5f71\u54cd<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/ivig\/ivig-for-multiple-myeloma-mm\/#What_Is_the_Prevalence_of_Multiple_Myeloma_in_the_US\" >\u7f8e\u56fd\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u7684\u60a3\u75c5\u7387\u662f\u591a\u5c11\uff1f<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/ivig\/ivig-for-multiple-myeloma-mm\/#How_Can_IVIG_Therapy_Help_Multiple_Myeloma_Patients\" >IVIG \u7597\u6cd5\u5982\u4f55\u5e2e\u52a9\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u60a3\u8005\uff1f<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/ivig\/ivig-for-multiple-myeloma-mm\/#How_Does_IVIG_Therapy_Work\" >IVIG \u7597\u6cd5\u5982\u4f55\u8d77\u4f5c\u7528\uff1f<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/ivig\/ivig-for-multiple-myeloma-mm\/#What_Is_the_Standard_Dose_of_IVIG_for_Multiple_Myeloma_Patients\" >\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u60a3\u8005\u7684 IVIG \u6807\u51c6\u5242\u91cf\u662f\u591a\u5c11\uff1f<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/ivig\/ivig-for-multiple-myeloma-mm\/#Who_Can_Benefit_From_IVIG_Therapy\" >\u8c01\u53ef\u4ee5\u4ece IVIG \u7597\u6cd5\u4e2d\u53d7\u76ca\uff1f<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Basics_of_Multiple_Myeloma_and_How_It_Affects_the_Immune_System\"><\/span><strong>\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u7684\u57fa\u7840\u77e5\u8bc6\u53ca\u5176\u5bf9\u514d\u75ab\u7cfb\u7edf\u7684\u5f71\u54cd<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u662f\u4e00\u79cd\u6e90\u81ea\u9aa8\u9ad3\u5e76\u5f71\u54cd\u6d46\u7ec6\u80de\u7684\u764c\u75c7\u3002\u5b83\u4e5f\u88ab\u79f0\u4e3a<strong><em> <\/em><\/strong>\u201c\u6d46\u7ec6\u80de\u764c\u201d\uff0c\u5355\u4e2a\u6d46\u7ec6\u80de\u53d1\u751f\u764c\u53d8\uff0c\u4e0d\u65ad\u589e\u6b96\uff0c\u5e76\u5728\u9aa8\u9ad3\u4e2d\u4e0d\u65ad\u7d2f\u79ef\u3002\u6700\u7ec8\uff0c\u764c\u6027\u6d46\u7ec6\u80de\uff08\u4e5f\u79f0\u4e3a\u9aa8\u9ad3\u7624\u7ec6\u80de\uff09\u4f1a\u6324\u6389\u9aa8\u9ad3\u4e2d\u5065\u5eb7\u7684\u9020\u8840\u7ec6\u80de\u3002&nbsp;<\/p>\n\n\n\n<p>\u6b64\u5916\uff0c\u764c\u53d8\u7684\u6d46\u7ec6\u80de\u4f1a\u4ea7\u751f\u5f02\u5e38\u7684\u3001\u65e0\u6548\u7684\u6297\u4f53\uff0c\u79f0\u4e3a M \u86cb\u767d\uff0c\u65e0\u6cd5\u62b5\u6297\u611f\u67d3\u3002&nbsp;<\/p>\n\n\n\n<p>\u6b64\u5916\uff0c\u5316\u7597\u548c\u5e72\u7ec6\u80de\u79fb\u690d\u7b49\u9aa8\u9ad3\u7624\u6cbb\u7597\u624b\u6bb5\u4f1a\u524a\u5f31\u60a3\u8005\u7684\u514d\u75ab\u7cfb\u7edf\u3002\u8fd9\u4e9b\u7597\u6cd5\u4e0d\u4ec5\u4f1a\u6740\u6b7b\u764c\u7ec6\u80de\uff0c\u8fd8\u4f1a\u7834\u574f\u5065\u5eb7\u7ec6\u80de\uff0c\u5bfc\u81f4\u5065\u5eb7\u6d46\u7ec6\u80de\u6570\u91cf\u548c\u6297\u4f53\u6c34\u5e73\u964d\u4f4e\u3002\u56e0\u6b64\uff0c\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u60a3\u8005\u6781\u6613\u611f\u67d3\u80ba\u708e\uff08\u547c\u5438\u9053\u611f\u67d3\uff09\u7b49\u75be\u75c5\u3002&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_Is_the_Prevalence_of_Multiple_Myeloma_in_the_US\"><\/span><strong>\u7f8e\u56fd\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u7684\u60a3\u75c5\u7387\u662f\u591a\u5c11\uff1f<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>\u6839\u636e <a href=\"https:\/\/www.cancer.org\/cancer\/types\/multiple-myeloma\/about\/key-statistics.html\">\u7f8e\u56fd\u764c\u75c7\u534f\u4f1a<\/a> \u636e\u4f30\u8ba1\uff0c2024\u5e74\u9884\u8ba1\u5c06\u51fa\u73b0\u8d85\u8fc735,000\u4f8b\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u65b0\u75c5\u4f8b\uff0c\u7ea612,540\u4eba\u6b7b\u4ea1\u3002&nbsp;<\/p>\n\n\n\n<p>\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u5728\u8001\u5e74\u4eba\u4e2d\u66f4\u4e3a\u5e38\u89c1\uff0c\u5e73\u5747\u53d1\u75c5\u5e74\u9f84\u4e3a65-69\u5c81\u3002&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"How_Can_IVIG_Therapy_Help_Multiple_Myeloma_Patients\"><\/span><strong>IVIG \u7597\u6cd5\u5982\u4f55\u5e2e\u52a9\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u60a3\u8005\uff1f<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>\u51e0\u5341\u5e74\u6765\uff0cIVIG \u7597\u6cd5\u4e00\u76f4\u7528\u4e8e\u6cbb\u7597\u5404\u79cd\u514d\u75ab\u76f8\u5173\u75be\u75c5\uff0c\u5305\u62ec\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u3002&nbsp;<\/p>\n\n\n\n<p>\u5bf9\u4e8e\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\uff0c\u9759\u8109\u6ce8\u5c04\u514d\u75ab\u7403\u86cb\u767d\uff08IVIG\uff09\u7597\u6cd5\u53ef\u4ee5\u6682\u65f6\u4e3a\u60a3\u8005\u63d0\u4f9b\u4e00\u7cfb\u5217\u6297\u4f53\uff0c\u6709\u52a9\u4e8e\u6539\u5584\u5176\u6574\u4f53\u514d\u75ab\u529f\u80fd\u3002\u8fd9\u4e9b\u6297\u4f53\u53ef\u4ee5\u8bc6\u522b\u5e76\u62b5\u6297\u60a3\u8005\u81ea\u8eab\u514d\u75ab\u7cfb\u7edf\u53d7\u635f\u800c\u65e0\u6cd5\u62b5\u5fa1\u7684\u611f\u67d3\u3002<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"How_Does_IVIG_Therapy_Work\"><\/span><strong>IVIG \u7597\u6cd5\u5982\u4f55\u8d77\u4f5c\u7528\uff1f<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignright size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"420\" height=\"270\" src=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/10\/multiple-myeloma.jpg\" alt=\"Multiple myeloma concept illustration\" class=\"wp-image-26670\" srcset=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/10\/multiple-myeloma.jpg 420w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/10\/multiple-myeloma-300x193.jpg 300w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/10\/multiple-myeloma-86x55.jpg 86w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/10\/multiple-myeloma-167x107.jpg 167w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/10\/multiple-myeloma-280x180.jpg 280w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/10\/multiple-myeloma-370x238.jpg 370w\" sizes=\"auto, (max-width: 420px) 100vw, 420px\" \/><\/figure>\n<\/div>\n\n\n<p>\u867d\u7136\u9759\u8109\u6ce8\u5c04\u514d\u75ab\u7403\u86cb\u767d\uff08IVIG\uff09\u7597\u6cd5\u7684\u5177\u4f53\u4f5c\u7528\u673a\u5236\u5c1a\u4e0d\u6e05\u695a\uff0c\u4f46\u7814\u7a76\u8868\u660e\uff0c\u5b83\u53ef\u4ee5\u589e\u5f3a\u673a\u4f53\u62b5\u6297\u611f\u67d3\u7684\u514d\u75ab\u53cd\u5e94\u3002\u5bf9\u4e8e\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u60a3\u8005\uff0cIVIG \u53ef\u4ee5\u53d1\u6325\u4ee5\u4e0b\u6709\u76ca\u4f5c\u7528\uff1a<\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><strong>\u51cf\u5c11\u590d\u53d1\u6027\u611f\u67d3\u7684\u9891\u7387<\/strong><\/h4>\n\n\n\n<p>IVIG\u7597\u6cd5\u901a\u8fc7\u4ea7\u751f\u6297\u4f53\u6765\u589e\u5f3a\u60a3\u8005\u7684\u514d\u75ab\u7cfb\u7edf\u3002\u591a\u9879\u7814\u7a76\u8868\u660e\uff0cIVIG\u7597\u6cd5\u6709\u52a9\u4e8e\u964d\u4f4e\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u60a3\u8005\u590d\u53d1\u6027\u611f\u67d3\uff08\u5305\u62ec3\u7ea7\u611f\u67d3\uff09\u7684\u53d1\u751f\u7387\u3002&nbsp;<\/p>\n\n\n\n<p>\u4f8b\u5982\uff0c\u53d1\u8868\u4e8e <a href=\"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article\/4\/6\/440\/729755\/IVIg-Use-Associated-with-Ten-Fold-Reduction-of\">\u300a\u8840\u764c\u53d1\u73b0\u300b<\/a> \u62a5\u9053\u79f0\uff0c\u9759\u8109\u6ce8\u5c04\u514d\u75ab\u7403\u86cb\u767d\u6cbb\u7597\u53ef\u964d\u4f4e\u590d\u53d1\u6216\u96be\u6cbb\u6027\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u60a3\u800590%\u5f15\u8d77\u76843\u7ea7\u548c5\u7ea7\u611f\u67d3\u98ce\u9669\u3002\u7814\u7a76\u4eba\u5458\u8fdb\u4e00\u6b65\u5f97\u51fa\u7ed3\u8bba\uff0cIVIG\u6cbb\u7597\u5e94\u5728\u6574\u4e2a\u6cbb\u7597\u8fc7\u7a0b\u4e2d\u4ee5\u53ca\u6cbb\u7597\u540e\u8fdb\u884c\u3002<\/p>\n\n\n\n<div  id=\"call-to-action-3521701a878da4f808c94953d1bc2b27\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\t\u8be2\u95ee IVIG \u5bb6\u5ead\u8f93\u6db2\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"#form\">\u5b89\u6392\u54a8\u8be2<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h4 class=\"wp-block-heading\"><strong>\u5b83\u63d0\u4f9b\u88ab\u52a8\u514d\u75ab&nbsp;<\/strong><\/h4>\n\n\n\n<p>IVIG \u4e3a\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u60a3\u8005\u63d0\u4f9b\u88ab\u52a8\u514d\u75ab\uff0c\u5373\u5c06\u6765\u81ea\u4f9b\u4f53\u7684\u73b0\u6210\u6297\u4f53\u6ce8\u5165\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u60a3\u8005\u4f53\u5185\uff0c\u4ee5\u62b5\u6297\u611f\u67d3\u3002\u4e0e\u523a\u6fc0\u6d46\u7ec6\u80de\u4ea7\u751f\u6297\u4f53\u7684\u75ab\u82d7\u4e0d\u540c\uff0cIVIG \u7597\u6cd5\u4e3a\u60a3\u8005\u4f53\u5185\u8865\u5145\u5fc5\u9700\u7684\u6297\u4f53\uff0c\u63d0\u4f9b\u5373\u65f6\u4fdd\u62a4\u5e76\u6709\u6548\u62b5\u6297\u611f\u67d3\u3002&nbsp;<\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><strong>\u5177\u6709\u6297\u764c\u548c\u6297\u708e\u4f5c\u7528&nbsp;<\/strong><\/h4>\n\n\n\n<p>IVIG \u56e0\u5176\u6297\u708e\u7279\u6027\u800c\u95fb\u540d\uff0c\u5b83\u6709\u52a9\u4e8e\u8c03\u8282\u5404\u79cd\u81ea\u8eab\u514d\u75ab\u6027\u75be\u75c5\u4e2d\u8fc7\u5ea6\u6d3b\u8dc3\u7684\u514d\u75ab\u7cfb\u7edf\u3002<\/p>\n\n\n\n<p><a href=\"https:\/\/www.frontiersin.org\/journals\/immunology\/articles\/10.3389\/fimmu.2020.01816\/full\">\u6700\u8fd1\u7684\u7814\u7a76<\/a> MD \u5b89\u5fb7\u68ee\u764c\u75c7\u4e2d\u5fc3\u7684\u4e00\u9879\u7814\u7a76\u8868\u660e\uff0cIVIG \u7597\u6cd5\u53ef\u4ee5\u6291\u5236\u9aa8\u9ad3\u7624\u7ec6\u80de\uff08\u764c\u6027\u6d46\u7ec6\u80de\uff09\u7684\u751f\u957f\uff0c\u5e76\u5bfc\u81f4\u7ec6\u80de\u6b7b\u4ea1\u3002\u57fa\u4e8e\u8fd9\u4e9b\u53d1\u73b0\uff0c\u7814\u7a76\u4eba\u5458\u5f97\u51fa\u7ed3\u8bba\uff0cIVIG \u7597\u6cd5\u53ef\u80fd\u5177\u6709\u6297\u764c\u4f5c\u7528\uff0c\u5e76\u4e14\u5c06\u5176\u6dfb\u52a0\u5230 <a href=\"https:\/\/ameripharmaspecialty.com\/zh\/cancer\/darzalex-and-its-role-in-treating-multiple-myeloma\/\">\u6807\u51c6\u9aa8\u9ad3\u7624\u6cbb\u7597<\/a> \u53ef\u4ee5\u5e2e\u52a9\u83b7\u5f97\u66f4\u597d\u7684\u7ed3\u679c\u3002&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_Is_the_Standard_Dose_of_IVIG_for_Multiple_Myeloma_Patients\"><\/span><strong>\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u60a3\u8005\u7684 IVIG \u6807\u51c6\u5242\u91cf\u662f\u591a\u5c11\uff1f<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>\u9aa8\u9ad3\u7624\u60a3\u8005\u901a\u5e38\u6bcf3\u81f34\u5468\u63a5\u53d7\u4e00\u6b21\u9759\u8109\u6ce8\u5c04\u514d\u75ab\u7403\u86cb\u767d\uff08IVIG\uff09\uff0c\u5242\u91cf\u4e3a\u6bcf\u516c\u65a4\u4f53\u91cd0.4\u514b\u3002IVIG\u7684\u7ed9\u836f\u9891\u7387\u53ef\u80fd\u56e0\u60a3\u8005\u7684\u7a33\u6001\u514d\u75ab\u7403\u86cb\u767d\u6c34\u5e73\u800c\u5f02\u3002&nbsp;<\/p>\n\n\n\n<p>\u4f8b\u5982\uff0c\u4e00\u4e9b\u60a3\u8005\u53ef\u80fd\u9700\u8981\u6bcf\u6708\u8fdb\u884c\u4e00\u6b21 IVIG \u6cbb\u7597\uff0c\u800c\u5176\u4ed6\u60a3\u8005\u53ef\u80fd\u9700\u8981\u66f4\u9891\u7e41\u5730\u8fdb\u884c\u6cbb\u7597\u3002&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Who_Can_Benefit_From_IVIG_Therapy\"><\/span><strong>\u8c01\u53ef\u4ee5\u4ece IVIG \u7597\u6cd5\u4e2d\u53d7\u76ca\uff1f<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u60a3\u8005 <a href=\"https:\/\/ameripharmaspecialty.com\/zh\/other-health-conditions\/hypogammaglobulinemia\/\">\u4f4e\u4e19\u79cd\u7403\u86cb\u767d\u8840\u75c7<\/a> \uff08\u8840\u6db2\u4e2d\u6297\u4f53\u6c34\u5e73\u4f4e\uff09\u5e76\u4e14\u6781\u6613\u53d7\u5230\u590d\u53d1\u6027\u6216\u4e25\u91cd\u611f\u67d3\u7684\u4eba\u53ef\u4ee5\u4ece IVIG \u6cbb\u7597\u4e2d\u53d7\u76ca\u3002&nbsp;<\/p>\n\n\n\n<p>\u540c\u6837\uff0c\u6b63\u5728\u63a5\u53d7\u5316\u7597\u548c\u5e72\u7ec6\u80de\u79fb\u690d\u7684 MM \u60a3\u8005\u4e5f\u53ef\u4ee5\u4ece IVIG \u7597\u6cd5\u4e2d\u53d7\u76ca\uff0c\u56e0\u4e3a\u8fd9\u4e9b\u5f3a\u5316\u6cbb\u7597\u4f1a\u5f71\u54cd\u514d\u75ab\u7cfb\u7edf\u5e76\u589e\u52a0\u611f\u67d3\u7684\u98ce\u9669\u3002&nbsp;<\/p>\n\n\n\n<p>\u4f8b\u5982\uff0c\u4e00\u9879\u961f\u5217\u7814\u7a76\u8868\u660e\uff0c\u5728\u514d\u75ab\u7597\u6cd5\u4e2d\u4f7f\u7528 IVIG \u53ef\u663e\u8457 <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0006497123132678\">\u51cf\u5c11\u5404\u7ea7\u611f\u67d3 40%<\/a>.&nbsp;<\/p>\n\n\n\n<p>\u503c\u5f97\u6ce8\u610f\u7684\u662f\uff0cIVIG\u7597\u6cd5\u5e76\u975e\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u7684\u72ec\u7acb\u6cbb\u7597\u65b9\u6cd5\uff0c\u800c\u662f\u4e00\u79cd\u8f85\u52a9\u7597\u6cd5\uff0c\u65e8\u5728\u964d\u4f4e\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u60a3\u8005\u7684\u611f\u67d3\u98ce\u9669\u3002<\/p>","protected":false},"excerpt":{"rendered":"<p>IVIG \u7528\u4e8e\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u60a3\u8005\u7684\u652f\u6301\u6cbb\u7597\u3002\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u662f\u4e00\u79cd\u7f55\u89c1\u7684\u8840\u764c\uff0c\u5f62\u6210\u4e8e\u6d46\u7ec6\u80de\u3002\u6d46\u7ec6\u80de\u662f\u4e00\u79cd\u767d\u7ec6\u80de\uff0c\u5728\u6b63\u5e38\u60c5\u51b5\u4e0b\u4f1a\u4ea7\u751f\u6297\u4f53\u6765\u62b5\u6297\u611f\u67d3\u3002\u00a0<\/p>","protected":false},"author":25,"featured_media":26669,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[7],"tags":[31],"class_list":["post-26668","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ivig","tag-dr-mark-alfonso"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>IVIG for Multiple Myeloma (MM) - AmeriPharma\u00ae Specialty Care<\/title>\n<meta name=\"description\" content=\"Learn how IVIG is used as supportive therapy in patients with multiple myeloma. Topics include the beneficial effects of IVIG, dosing, and more.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/ivig\/ivig-for-multiple-myeloma-mm\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IVIG for Multiple Myeloma (MM) - AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"og:description\" content=\"Learn how IVIG is used as supportive therapy in patients with multiple myeloma. Topics include the beneficial effects of IVIG, dosing, and more.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ameripharmaspecialty.com\/zh\/ivig\/ivig-for-multiple-myeloma-mm\/\" \/>\n<meta property=\"og:site_name\" content=\"AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ameripharma\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-10-18T15:30:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/10\/ivig-patient.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dr. Mark Alfonso, PharmD, BCMTMS\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Mark Alfonso, PharmD, BCMTMS\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 \u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-multiple-myeloma-mm\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-multiple-myeloma-mm\\\/\"},\"author\":{\"name\":\"Dr. Mark Alfonso, PharmD, BCMTMS\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/91fbbfa457730010998bc804c0467310\"},\"headline\":\"IVIG for Multiple Myeloma (MM)\",\"datePublished\":\"2024-10-18T15:30:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-multiple-myeloma-mm\\\/\"},\"wordCount\":839,\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-multiple-myeloma-mm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/ivig-patient.jpg\",\"keywords\":[\"Dr. Mark Alfonso\"],\"articleSection\":[\"IVIG\"],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-multiple-myeloma-mm\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-multiple-myeloma-mm\\\/\",\"name\":\"IVIG for Multiple Myeloma (MM) - AmeriPharma\u00ae Specialty Care\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-multiple-myeloma-mm\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-multiple-myeloma-mm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/ivig-patient.jpg\",\"datePublished\":\"2024-10-18T15:30:00+00:00\",\"description\":\"Learn how IVIG is used as supportive therapy in patients with multiple myeloma. Topics include the beneficial effects of IVIG, dosing, and more.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-multiple-myeloma-mm\\\/#breadcrumb\"},\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-multiple-myeloma-mm\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-multiple-myeloma-mm\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/ivig-patient.jpg\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/ivig-patient.jpg\",\"width\":1280,\"height\":853,\"caption\":\"Nurse with patient receiving IVIG therapy for multiple myeloma\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/ivig\\\/ivig-for-multiple-myeloma-mm\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IVIG for Multiple Myeloma (MM)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"name\":\"AmeriPharma\u00ae Specialty Care\",\"description\":\"Specialty Care by AmeriPharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\",\"name\":\"Ameripharma Specialty Care\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"width\":400,\"height\":400,\"caption\":\"Ameripharma Specialty Care\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ameripharma\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/91fbbfa457730010998bc804c0467310\",\"name\":\"Dr. Mark Alfonso, PharmD, BCMTMS\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/df364e910b779452dd2f50a2c506c7f028521d079f2eb79d89b22b93f4bd45d0?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/df364e910b779452dd2f50a2c506c7f028521d079f2eb79d89b22b93f4bd45d0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/df364e910b779452dd2f50a2c506c7f028521d079f2eb79d89b22b93f4bd45d0?s=96&d=mm&r=g\",\"caption\":\"Dr. Mark Alfonso, PharmD, BCMTMS\"},\"description\":\"Dr. Mark Alfonso, PharmD was born and raised in Pueblo, CO. He received his pharmacy degree from the University of Colorado School of Pharmacy at the Anschutz Medical Campus in 2010. He was board certified in medication therapy management in 2022. The most rewarding part of his job is helping to answer patient questions and concerns. His areas of expertise are community pharmacy and medication therapy management. In his free time, he enjoys reading and running.\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/author\\\/mark-alfonso\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IVIG \u6cbb\u7597\u591a\u53d1\u6027\u9aa8\u9ad3\u7624 (MM) - AmeriPharma\u00ae \u4e13\u79d1\u62a4\u7406","description":"\u4e86\u89e3\u5982\u4f55\u4f7f\u7528\u9759\u8109\u6ce8\u5c04\u514d\u75ab\u7403\u86cb\u767d\uff08IVIG\uff09\u4f5c\u4e3a\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u60a3\u8005\u7684\u652f\u6301\u7597\u6cd5\u3002\u4e3b\u9898\u5305\u62ec\u9759\u8109\u6ce8\u5c04\u514d\u75ab\u7403\u86cb\u767d\uff08IVIG\uff09\u7684\u76ca\u5904\u3001\u5242\u91cf\u7b49\u3002","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ameripharmaspecialty.com\/zh\/ivig\/ivig-for-multiple-myeloma-mm\/","og_locale":"zh_CN","og_type":"article","og_title":"IVIG for Multiple Myeloma (MM) - AmeriPharma\u00ae Specialty Care","og_description":"Learn how IVIG is used as supportive therapy in patients with multiple myeloma. Topics include the beneficial effects of IVIG, dosing, and more.","og_url":"https:\/\/ameripharmaspecialty.com\/zh\/ivig\/ivig-for-multiple-myeloma-mm\/","og_site_name":"AmeriPharma\u00ae Specialty Care","article_publisher":"https:\/\/www.facebook.com\/ameripharma\/","article_published_time":"2024-10-18T15:30:00+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/10\/ivig-patient.jpg","type":"image\/jpeg"}],"author":"Dr. Mark Alfonso, PharmD, BCMTMS","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dr. Mark Alfonso, PharmD, BCMTMS","Est. reading time":"4 \u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-multiple-myeloma-mm\/#article","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-multiple-myeloma-mm\/"},"author":{"name":"Dr. Mark Alfonso, PharmD, BCMTMS","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/91fbbfa457730010998bc804c0467310"},"headline":"IVIG for Multiple Myeloma (MM)","datePublished":"2024-10-18T15:30:00+00:00","mainEntityOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-multiple-myeloma-mm\/"},"wordCount":839,"publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-multiple-myeloma-mm\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/10\/ivig-patient.jpg","keywords":["Dr. Mark Alfonso"],"articleSection":["IVIG"],"inLanguage":"zh-Hans"},{"@type":"WebPage","@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-multiple-myeloma-mm\/","url":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-multiple-myeloma-mm\/","name":"IVIG \u6cbb\u7597\u591a\u53d1\u6027\u9aa8\u9ad3\u7624 (MM) - AmeriPharma\u00ae \u4e13\u79d1\u62a4\u7406","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-multiple-myeloma-mm\/#primaryimage"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-multiple-myeloma-mm\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/10\/ivig-patient.jpg","datePublished":"2024-10-18T15:30:00+00:00","description":"\u4e86\u89e3\u5982\u4f55\u4f7f\u7528\u9759\u8109\u6ce8\u5c04\u514d\u75ab\u7403\u86cb\u767d\uff08IVIG\uff09\u4f5c\u4e3a\u591a\u53d1\u6027\u9aa8\u9ad3\u7624\u60a3\u8005\u7684\u652f\u6301\u7597\u6cd5\u3002\u4e3b\u9898\u5305\u62ec\u9759\u8109\u6ce8\u5c04\u514d\u75ab\u7403\u86cb\u767d\uff08IVIG\uff09\u7684\u76ca\u5904\u3001\u5242\u91cf\u7b49\u3002","breadcrumb":{"@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-multiple-myeloma-mm\/#breadcrumb"},"inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-multiple-myeloma-mm\/"]}]},{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-multiple-myeloma-mm\/#primaryimage","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/10\/ivig-patient.jpg","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/10\/ivig-patient.jpg","width":1280,"height":853,"caption":"Nurse with patient receiving IVIG therapy for multiple myeloma"},{"@type":"BreadcrumbList","@id":"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-for-multiple-myeloma-mm\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ameripharmaspecialty.com\/"},{"@type":"ListItem","position":2,"name":"IVIG for Multiple Myeloma (MM)"}]},{"@type":"WebSite","@id":"https:\/\/ameripharmaspecialty.com\/#website","url":"https:\/\/ameripharmaspecialty.com\/","name":"AmeriPharma\u00ae \u4e13\u4e1a\u62a4\u7406","description":"AmeriPharma \u7684\u4e13\u4e1a\u62a4\u7406","publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ameripharmaspecialty.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Organization","@id":"https:\/\/ameripharmaspecialty.com\/#organization","name":"\u7f8e\u56fd\u5236\u836f\u4e13\u4e1a\u62a4\u7406","url":"https:\/\/ameripharmaspecialty.com\/","logo":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","width":400,"height":400,"caption":"Ameripharma Specialty Care"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ameripharma\/"]},{"@type":"Person","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/91fbbfa457730010998bc804c0467310","name":"Mark Alfonso \u535a\u58eb\uff0c\u836f\u5b66\u535a\u58eb\uff0cBCMTMS","image":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/secure.gravatar.com\/avatar\/df364e910b779452dd2f50a2c506c7f028521d079f2eb79d89b22b93f4bd45d0?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/df364e910b779452dd2f50a2c506c7f028521d079f2eb79d89b22b93f4bd45d0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/df364e910b779452dd2f50a2c506c7f028521d079f2eb79d89b22b93f4bd45d0?s=96&d=mm&r=g","caption":"Dr. Mark Alfonso, PharmD, BCMTMS"},"description":"Mark Alfonso \u535a\u58eb\uff0c\u836f\u5b66\u535a\u58eb\uff0c\u5728\u79d1\u7f57\u62c9\u591a\u5dde\u666e\u97e6\u5e03\u6d1b\u51fa\u751f\u957f\u5927\u3002\u4ed6\u4e8e 2010 \u5e74\u5728\u79d1\u7f57\u62c9\u591a\u5927\u5b66\u5b89\u8212\u8328\u533b\u5b66\u9662\u836f\u5b66\u9662\u83b7\u5f97\u836f\u5b66\u5b66\u4f4d\u3002\u4ed6\u4e8e 2022 \u5e74\u83b7\u5f97\u836f\u7269\u6cbb\u7597\u7ba1\u7406\u59d4\u5458\u4f1a\u8ba4\u8bc1\u3002\u4ed6\u5de5\u4f5c\u4e2d\u6700\u6709\u6210\u5c31\u611f\u7684\u90e8\u5206\u662f\u5e2e\u52a9\u89e3\u7b54\u60a3\u8005\u7684\u7591\u95ee\u548c\u62c5\u5fe7\u3002\u4ed6\u7684\u4e13\u4e1a\u9886\u57df\u662f\u793e\u533a\u836f\u623f\u548c\u836f\u7269\u6cbb\u7597\u7ba1\u7406\u3002\u95f2\u6687\u65f6\uff0c\u4ed6\u559c\u6b22\u9605\u8bfb\u548c\u8dd1\u6b65\u3002","url":"https:\/\/ameripharmaspecialty.com\/zh\/author\/mark-alfonso\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/10\/ivig-patient.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/10\/ivig-patient-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/10\/ivig-patient-300x200.jpg",300,200,true],"medium_large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/10\/ivig-patient-768x512.jpg",768,512,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/10\/ivig-patient-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/10\/ivig-patient.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/10\/ivig-patient.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/10\/ivig-patient.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/10\/ivig-patient-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/10\/ivig-patient-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/10\/ivig-patient-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/10\/ivig-patient-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/10\/ivig-patient-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/10\/ivig-patient-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/10\/ivig-patient-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/10\/ivig-patient-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/10\/ivig-patient.jpg",1280,853,false]},"uagb_author_info":{"display_name":"Dr. Mark Alfonso, PharmD, BCMTMS","author_link":"https:\/\/ameripharmaspecialty.com\/zh\/author\/mark-alfonso\/"},"uagb_comment_info":0,"uagb_excerpt":"IVIG is used as a supportive therapy in patients with multiple myeloma. Multiple myeloma is a rare type of blood cancer that forms in plasma cells, a type of white blood cell that produces antibodies to fight infections under normal conditions.\u00a0","rttpg_featured_image_url":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/10\/ivig-patient.jpg",1280,853,false],"landscape":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/10\/ivig-patient.jpg",1280,853,false],"portraits":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/10\/ivig-patient.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/10\/ivig-patient-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/10\/ivig-patient-300x200.jpg",300,200,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/10\/ivig-patient-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/10\/ivig-patient.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/10\/ivig-patient.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/10\/ivig-patient.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/10\/ivig-patient-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/10\/ivig-patient-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/10\/ivig-patient-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/10\/ivig-patient-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/10\/ivig-patient-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/10\/ivig-patient-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/10\/ivig-patient-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/10\/ivig-patient-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/10\/ivig-patient.jpg",1280,853,false]},"rttpg_author":{"display_name":"Dr. Mark Alfonso, PharmD, BCMTMS","author_link":"https:\/\/ameripharmaspecialty.com\/zh\/author\/mark-alfonso\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/ameripharmaspecialty.com\/zh\/category\/ivig\/\" rel=\"category tag\">IVIG<\/a>","rttpg_excerpt":"IVIG is used as a supportive therapy in patients with multiple myeloma. Multiple myeloma is a rare type of blood cancer that forms in plasma cells, a type of white blood cell that produces antibodies to fight infections under normal conditions.\u00a0","_links":{"self":[{"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/posts\/26668","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/users\/25"}],"replies":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/comments?post=26668"}],"version-history":[{"count":0,"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/posts\/26668\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/media\/26669"}],"wp:attachment":[{"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/media?parent=26668"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/categories?post=26668"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/tags?post=26668"}],"curies":[{"name":"\u53ef\u6e7f\u6027\u7c89\u5242","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}